Exact Sciences (EXAS)

• Market cap: $8.31B
• 1 day: 0.16%
• 5 days: 1.17%
• 1 month: -5.92%
• 3 months: -21.82%
• 6 months: -31.79%
• Year to date: -20.97%
• 1 year: -32.73%
• 5 years: -22.30%
• 10 years: 100.04%
• Sector: Healthcare
• Industry: Medical Laboratories

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

123% more call options, than puts

Call options by funds: $251M | Put options by funds: $112M

2% less first-time investments, than exits

New positions opened: 87 | Existing positions closed: 89

1.07% less ownership

Funds ownership: 101.35% [Q3] → 100.28% (-1.07%) [Q4]

2% less funds holding

Funds holding: 586 [Q3] → 574 (-12) [Q4]

11% less repeat investments, than reductions

Existing positions increased: 178 | Existing positions reduced: 199

18% less capital invested

Capital invested by funds: $12.7B [Q3] → $10.4B (-$2.33B) [Q4]

22% less funds holding in top 10

Funds holding in top 10: 9 [Q3] → 7 (-2) [Q4]

Research analyst outlook

6 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $52 16% upside
• Avg. target: $65 44% upside
• High target: $73 62% upside

6 analyst ratings

• positive: 5 83%
• neutral: 1 17%
• negative: 0 0%

RBC Capital Gerard Cassidy 48% 1-year accuracy 16 / 33 met price target	16% upside $52	Sector Perform Initiated	13 Mar 2025
Piper Sandler David Westenberg 49% 1-year accuracy 21 / 43 met price target	56% upside $70	Overweight Maintained	26 Feb 2025
Scotiabank Sung Ji Nam 25% 1-year accuracy 6 / 24 met price target	62% upside $73	Sector Outperform Maintained	24 Feb 2025
B of A Securities Derik De Bruin 40% 1-year accuracy 8 / 20 met price target	44% upside $65	Buy Maintained	20 Feb 2025
Barclays Luke Sergott 25% 1-year accuracy 13 / 51 met price target	44% upside $65	Overweight Maintained	20 Feb 2025